Our data suggested that the upregulation of nAChR may be a general self-defense mechanism for SCLC cells, to reduce the cytotoxic effects of cisplatin and potentially other chemotherapies—while nicotine or cotinine could enhance such an effect. Here, CHRNA4 is linked to small cell lung carcinoma.